| Cell type (source) | Agonist (dose and exposure time) | Secreted proteins induced by LPS | Secreted proteins induced by Poly(I:C) | References |
| rBM-MSCs (Sprague Dawley rats) cultured on titanium surface | LPS (1 μg/mL for 6–72 h) | TNF-α, IL-1β | NA | [24] | rBM-MSCs (Sprague Dawley rats) | LPS (1 μg/mL for 6 h) | TNF-α, IL-1β | NA | [25] | mBM-MSCs (C57BL/6J mice) | LPS or Poly(I:C) (20 μg/mL for 24–72 h or 10 ng/mL–20 μg/mL for 7 days) | IL-6 | IL-6 | [15] | mBM-MSCs (C57BL/6J mice) | LPS (100 ng/mL for 24 h) | IL-6, VEGF-A | NA | [73, 74] | mBM-MSCs (C57BL/6 mice) | LPS (1 μg/mL for 48 h) or Poly(I:C) (20 μg/mL for 48 h) | IL-6 | IL-6 | [56] | mBM-MSCs (C57BL/10J mice) | LPS (0.01 to 10 μg/mL for 48 h) | VEGF | NA | [22] | mBM-MSCs (C57BL/6J mice) | LPS (1 μg/mL for 24 h) or Poly(I:C) (50 μg/mL for 24 h) | IL-6, IL-1β, IFN-γ | IL-6, TGF-β, IL-10, IL-1β, and IFN-β | [58] | mBM-MSCs (C57BL/6J mice) | LPS (0.01–10 mg/mL for 24 h) or Poly(I:C) (0.01–10 mg/mL for 24 h) | IL-6 | IL-6 | [94] | mBM-MSCs (C57BL/6J mice) | LPS (1000 ng/mL for 3 days) | IL-6, IL-1β | NA | [95] | hMSCs | LPS (10 ng/mL for 24 or 48 h) or Poly(I:C) (1 μg/mL for 24 or 48 h) | IL-6, IL-8, IP-10, TNF-α | IL-10, IL-12 | [19] | hMSCs | LPS (10 ng/mL for 1 h) or Poly(I:C) (1 μg/mL for 1 h)+48 h without stimuli | IL-6, IL-8 | IP-10, RANTES | [20] | hBM-MSCs | LPS (10 μg/mL for 18 h) or Poly(I:C) (30 μg/mL for 18 h) | IL-6, iL-8, RANTES | IL-6, IL-8, RANTES | [96] | hBM-MSCs | LPS (10 μg/mL for 48 h) | IL-6, MCP-1, IL-8, TNF-α, GM-CSF, IL-1β, G-CSF, MIP-1β, IFN-γ, IL-17, and IL-4 | NA | [97] | hBM-MSCs | Poly(I:C) (1 μM for 4–24 h) | NA | IL-6, IL-8, IFN type I | [63] | hBM-MSCs | LPS (1–1000 ng/mL for 48 h) or Poly(I:C) (0.02–20 μg/mL for 48 h) | IL-6, IL-8, RANTES, IL-1β | IL-6, IL-8, RANTES, IL-1β | [56] | hBM-MSCs | LPS (5 μg/mL for 24 h) or Poly(I:C) (50 μg/mL for 24 h) | IL-6 | IL-6 | [57] | hBM-MSCs | LPS (10 μg/mL for 18 h) or Poly(I:C) (30 μg/mL for 18 h) | IL-6 | IL-6, IL-23 | [16] | hBM-MSCs | LPS (100 ng/mL for 24 h) or Poly(I:C) (100 μg/mL for 24 h) | IL-6, IL-8, GM-CSF | IL-6, IL-8, GM-CSF, and IFN-β | [98] | hBM-MSCs | LPS (10 ng/mL for 4 h) or Poly(I:C) (1–5 μM/mL for 4 h)+24 h without stimuli | IL-6, IL-8, IP-10, RANTES, and IFN-α | IL-6, IL-8, IP-10, RANTES, and IFN-α | [99] | hBM-MSCs | Poly(I:C) (5 μg/mL for 24 h) | NA | IL-6, IP-10 | [100] | hBM-MSCs | LPS (10 μg/mL for 48 h) | IL-6, GM-CSF, G-CSF, M-CSF, and IL-11 | NA | [101] | hBM-MSCs | LPS (10 ng/mL for 24 h) | IL-6, VEGF, MCP-1, IL-8, IP-10, RANTES, GM-CSF, MIP-1α, MIP-1β, SDF-1α, IL-1RA, GRO-α, IL-1α, IL-2, IL-31, and eotaxin | NA | [77] |
|
|